3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Smoldering Multiple Myeloma
3
Monoclonal Gammopathy of Undetermined Significance
3
Stomach Neoplasms
2
Prostatic Neoplasms
2
Multiple Myeloma
2
Uterine Cervical Dysplasia
1
Thrombocythemia, Essential
1
Rectal Neoplasms
1
Psychological Well-Being
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Polycystic Ovary Syndrome
1
Neurofibromatosis 1
1
Neoplasms
1
Myelodysplastic Syndromes
1
Motor Activity
1
Lung Neoplasms
1
Joint Diseases
1
Gastritis, Atrophic
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Castration Sensitive Prostate Cancer
1
Breast Neoplasms
1
Arthralgia
1
Interventions
Exercise
55
Resistance Training
9
Nutritional Status
6
Control Groups
5
Surveys and Questionnaires
4
Standard of Care
4
Diet
4
Preoperative Exercise
3
Physical Therapy Modalities
3
Nutrition Assessment
3
Methods
3
High-Intensity Interval Training
3
Counseling
3
lime
2
Vitamin D
2
Palliative Care
2
Interviews as Topic
2
Exercise Therapy
2
Exercise Test
2
Dosage Forms
2
Diet Therapy
2
Blood Specimen Collection
2
pembrolizumab
1
diacetamate
1
cytisine
1
cemiplimab
1
beta-Glucans
1
avelumab
1
YES1 protein, human
1
Whey Proteins
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Motor Activity
×
Curcumin
×
1 year
×
Clear all
NCT04871412
2026-01-30
POISE
Ottawa Hospital Research Institute
Phase 3
Recruiting
20 enrolled